Felbamate (Wallace Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Felbamate drug offered from Wallace Pharmaceuticals Inc.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Wallace Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | felbamate |
SUBSTANCE NAME: | FELBAMATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2011-11-11 |
END MARKETING DATE: | 0000-00-00 |
Felbamate HUMAN PRESCRIPTION DRUG Details:
Item Description | Felbamate from Wallace Pharmaceuticals Inc. |
LABELER NAME: | Wallace Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 400(mg/1) |
START MARKETING DATE: | 2011-11-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51525-0430_d6f39261-d969-431a-a372-0487262546ca |
PRODUCT NDC: | 51525-0430 |
APPLICATION NUMBER: | NDA020189 |
Other FELBAMATE Pharmaceutical Manufacturers / Labelers: